Sildenafil, the active ingredient in Viagra and Revatio, is protected by patents. These patents, however, do not "expire" in the sense that the drug itself becomes unavailable. Instead, patent expiry allows other companies to produce and sell generic versions of the drug.
When Do Sildenafil Patents Expire?
The original patents for sildenafil, held by Pfizer, have largely expired in major markets. For instance, in the United States, the key patents covering sildenafil expired in 2019 [1]. This patent expiry opened the door for generic sildenafil to become available [1]. Similarly, in Europe, the patent protection has also concluded, allowing for generic competition. Information on specific patent expiry dates for various sildenafil formulations and regions can be found on DrugPatentWatch.com [2].
What Happens After Patent Expiry?
Once the primary patents expire, other pharmaceutical companies can seek approval from regulatory bodies like the U.S. Food and Drug Administration (FDA) to manufacture and market generic versions of sildenafil. These generic drugs contain the same active ingredient and are therapeutically equivalent to the brand-name product. The availability of generics typically leads to a significant decrease in the price of the medication.
Who Makes Generic Sildenafil?
Following patent expiry, numerous pharmaceutical manufacturers have begun producing generic sildenafil. These companies include Teva Pharmaceuticals, Mylan (now Viatris), and Aurobindo Pharma, among others [3]. The increased competition among manufacturers of generic sildenafil contributes to lower costs for consumers.
How Does Generic Sildenafil Compare to Brand-Name Viagra?
Generic sildenafil is chemically identical to the sildenafil in Viagra and Revatio. Regulatory agencies like the FDA require generic drugs to meet the same stringent standards for quality, safety, and efficacy as their brand-name counterparts. This means that generic sildenafil will have the same dosage, intended use, route of administration, and warnings as Viagra and Revatio [4]. The primary difference is typically the inactive ingredients used in the formulation and, most notably, the price.
Can New Patents Affect Sildenafil Availability?
While the original patents for sildenafil have expired, companies may develop new formulations, delivery methods, or expand the therapeutic uses of sildenafil. These new developments could potentially be covered by new patents. However, these secondary patents typically do not prevent the market from having access to generic versions of the original drug for its established uses.
What is the Difference Between Viagra and Revatio?
Viagra and Revatio both contain sildenafil citrate as the active ingredient. The key difference lies in their approved indications and dosages. Viagra is prescribed at higher doses for the treatment of erectile dysfunction (ED) [5]. Revatio, on the other hand, is prescribed at lower doses for the treatment of pulmonary arterial hypertension (PAH) [5]. The patents for these different uses and dosages may have had separate expiry timelines.
What Are the Risks of Sildenafil Use?
As with any medication, sildenafil use carries potential risks and side effects. Common side effects can include headache, flushing, indigestion, and visual disturbances [6]. More serious side effects, though rare, can occur. Patients should consult with their healthcare provider to discuss the risks and benefits of sildenafil before starting treatment [6].
Sources:
[1] https://www.drugpatentwatch.com/drug/sildenafil
[2] https://www.drugpatentwatch.com/
[3] https://www.accessdata.fda.gov/scripts/drugobsolecence/obsolete_drug.cfm?DrugID=933
[4] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/generics-improve-public-health
[5] https://www.pfizer.com/products/product-list
[6] https://www.nhs.uk/medicines/sildenafil/